COL2A1 and acute myeloid leukemia: Decreased expression of COL2A1 reduces the osteogenic protein, destroys normal ECM structure, promotes the remodeling of the BM microenvironment toward the direction of tumor promotion, and participates in the mutual promotion between TME and AML (35, 36).